POKRIVČÁK, Tomáš, Jiří NAVRÁTIL, Alexandr POPRACH, Michal STANÍK a Igor KISS. Long-Term Efficacy and Safety of Enzalutamide Monotherapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Report. CASE REPORTS IN ONCOLOGY. BASEL: KARGER, 2024, roč. 17, č. 1, s. 537-542. ISSN 1662-6575. Dostupné z: https://dx.doi.org/10.1159/000538124. |
Další formáty:
BibTeX
LaTeX
RIS
@article{2407957, author = {Pokrivčák, Tomáš and Navrátil, Jiří and Poprach, Alexandr and Staník, Michal and Kiss, Igor}, article_location = {BASEL}, article_number = {1}, doi = {http://dx.doi.org/10.1159/000538124}, keywords = {Enzalutamide; Metastatic castration-resistant prostate cancer; Aged 75 and over; Comorbidity}, language = {eng}, issn = {1662-6575}, journal = {CASE REPORTS IN ONCOLOGY}, title = {Long-Term Efficacy and Safety of Enzalutamide Monotherapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Report}, url = {https://karger.com/cro/article/17/1/537/898017/Long-Term-Efficacy-and-Safety-of-Enzalutamide}, volume = {17}, year = {2024} }
TY - JOUR ID - 2407957 AU - Pokrivčák, Tomáš - Navrátil, Jiří - Poprach, Alexandr - Staník, Michal - Kiss, Igor PY - 2024 TI - Long-Term Efficacy and Safety of Enzalutamide Monotherapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Report JF - CASE REPORTS IN ONCOLOGY VL - 17 IS - 1 SP - 537-542 EP - 537-542 PB - KARGER SN - 16626575 KW - Enzalutamide KW - Metastatic castration-resistant prostate cancer KW - Aged 75 and over KW - Comorbidity UR - https://karger.com/cro/article/17/1/537/898017/Long-Term-Efficacy-and-Safety-of-Enzalutamide N2 - Introduction: Prostate cancer is one of the most common cancers in men. Despite the sharp rise in incidence, mortality is decreasing. ARTA preparations are preferred options for asymptomatic or mildly symptomatic patients with mCRPC. The use of enzalutamide in elderly patients with mCRPC is risky and depends on a number of factors. An increased risk of falls and fractures has been shown. Case Presentation: We present a case report of an elderly patient with mCRPC treated with enzalutamide with very good long-term tolerance and efficacy. Conclusion: Despite the older age, no reduction of therapy was necessary in the patient due to good tolerance. Administration of enzalutamide in full doses resulted in a very good effect of therapy. ER -
POKRIVČÁK, Tomáš, Jiří NAVRÁTIL, Alexandr POPRACH, Michal STANÍK a Igor KISS. Long-Term Efficacy and Safety of Enzalutamide Monotherapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Report. \textit{CASE REPORTS IN ONCOLOGY}. BASEL: KARGER, 2024, roč.~17, č.~1, s.~537-542. ISSN~1662-6575. Dostupné z: https://dx.doi.org/10.1159/000538124.
|